Indivior PLC Ordinary Shares (INDV) Dividend History

Indivior PLC is a British pharmaceutical company specializing in the development and marketing of treatments for substance use disorders, including addiction to opioids and alcohol. Founded in 2014 as a spin-off from Reckitt Benckiser, Indivior focuses on innovative medications such as Suboxone for opioid dependence. The company operates globally, providing therapies aimed at improving patient outcomes and addressing the challenges of addiction.

Website: https://www.indivior.com

Dividend History

Indivior PLC Ordinary Shares currently does not pay dividends

Company News

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference

Addex Therapeutics announced that it will present preclinical data on its GABAB positive allosteric modulator cough program at the American Cough Conference. The company's lead drug candidate is ready to start IND enabling studies.

GlobeNewswire Inc.
Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details

Indivior cuts its FY24 revenue guidance due to lower-than-expected SUBLOCADE revenue amid competition from a competing injectable product, leading to a decline in the company's stock price.

Benzinga
Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates

Indivior (INDV) delivered earnings and revenue surprises of -2.63% and 5.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: ECOR
European stocks hit new record for first time in two years as Nvidia sparks semiconductor rally

European stocks were on course for a new record high for the first time in more than two years as the semiconductor sector got a fresh leg up from Nvidia’s sparkling results.

MarketWatch

Featured Companies: MC NVDA RR

Page data last updated 07/23/2025 01:08:35 UTC